Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Tentative FDA approval for generic analgesic

Oct. 18, 1996

No Comments

Merck & Co. reveals new series of tachykinin antagonists

Oct. 18, 1996

No Comments

Yamanouchi's CNS products in the pipeline

Oct. 11, 1996

No Comments

Novel treatment for chronic fatigue syndrome available in Canada

Oct. 11, 1996

No Comments

Novel free radical-scavenging and neuroprotective substance isolated by Japanese researchers

Oct. 11, 1996

No Comments

Calpain inhibitors reported by Warner-Lambert

Oct. 11, 1996

No Comments

New muscarinic antagonists from Schering-Plough

Oct. 11, 1996

No Comments

Copaxone approvable for MS

Oct. 11, 1996

No Comments

FDA approval for Taro generic drug

Oct. 11, 1996

No Comments

First launch for olanzapine

Oct. 11, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Neurology/psychiatric
RSS

Tentative FDA approval for generic analgesic

Merck & Co. reveals new series of tachykinin antagonists

Yamanouchi's CNS products in the pipeline

Novel treatment for chronic fatigue syndrome available in Canada

Novel free radical-scavenging and neuroprotective substance isolated by Japanese researchers

Calpain inhibitors reported by Warner-Lambert

New muscarinic antagonists from Schering-Plough

Copaxone approvable for MS

FDA approval for Taro generic drug

First launch for olanzapine

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

‘Evo’ AI can design complete genomes

Neurology/psychiatric RSS

Neurology/psychiatric
RSS